-transparent.png){kind=logo}
Using glucagon-like peptide-1 N-terminus and C-terminus directed antisera, we investigated concentration and molecular forms of GLP-1 immunoreactivity (IR) in extracts of various tissues of the dog. GLP-1 IR measured with C-terminus-directed antiserum R2337 (GLP-1 IR-CT) was high in the ileum, appendix, jejunum, colon, and gastric fundus and body. GLP-1 IR measured with N-terminus-directed antiserum R1043 (GLP-1 IR-NT) was high only in the pancreas, and gastric fundus and body. Only GLP-1 IR-CT was found in the hypothalamus, thalamus and medulla oblongata. No immunoreactive materials were detected in the liver, spleen and kidney. Gel-filtration with Sephadex G-50 showed two peaks of both GLP-1 IR-CT and GLP-1 IR-NT, at 10kd and at the position of GLP-1 (1-36 amide) in the pancreatic extract, and one peak at 10kd in the stomach extract. Ileal extracts showed 3 peaks of GLP-1 IR-CT at 10kd, at the position of GLP-1(1-36 amide) and GLP-1(7-36 amide), respectively, but GLP-1 IR-NT was coeluted with GLP-1(1-36 amide). Hypothalamic extracts showed a single peak at the position of GLP-1(7-36 amide). These results suggest that processing of preproglucagon differs in different organs, and that the main GLP-1-related products are a large molecular form and GLP-1(1-36 amide) or GLP-1(1-37) in the pancreas, and GLP-1(7-36 amide) or GLP-1 (7-37) in the ileum and hypothalamus.
K Suda, and
H Takahashi, and
N Fukase, and
H Manaka, and
M Tominaga, and
H Sasaki
September 1985,
The Journal of clinical endocrinology and metabolism,
K Suda, and
H Takahashi, and
N Fukase, and
H Manaka, and
M Tominaga, and
H Sasaki
January 1989,
General and comparative endocrinology,
K Suda, and
H Takahashi, and
N Fukase, and
H Manaka, and
M Tominaga, and
H Sasaki
November 1985,
FEBS letters,
K Suda, and
H Takahashi, and
N Fukase, and
H Manaka, and
M Tominaga, and
H Sasaki
March 1983,
Endocrinology,
K Suda, and
H Takahashi, and
N Fukase, and
H Manaka, and
M Tominaga, and
H Sasaki
July 2003,
Scandinavian journal of gastroenterology,
K Suda, and
H Takahashi, and
N Fukase, and
H Manaka, and
M Tominaga, and
H Sasaki
June 2016,
Current opinion in lipidology,
K Suda, and
H Takahashi, and
N Fukase, and
H Manaka, and
M Tominaga, and
H Sasaki
July 2002,
Nihon rinsho. Japanese journal of clinical medicine,
K Suda, and
H Takahashi, and
N Fukase, and
H Manaka, and
M Tominaga, and
H Sasaki
November 1997,
Endocrinology,
K Suda, and
H Takahashi, and
N Fukase, and
H Manaka, and
M Tominaga, and
H Sasaki
October 1978,
Life sciences,
K Suda, and
H Takahashi, and
N Fukase, and
H Manaka, and
M Tominaga, and
H Sasaki
January 1996,
European journal of drug metabolism and pharmacokinetics,
